Vara, Interview with CEO Jonas Muff
Summary
In conjunction with the announcement, Jonas Muff, the CEO of the company, answered our questions about Vara, the product they provide and what they want to solve through it, the funding itself and future plans. ● Our AI decision referral pathway (published in Lancet Digital Health and developed in Germany) augments our partners’ radiologists, such that they can screen more women and achieve better efficacy. The study is led by Prof. Dr. Alexander Katalinic, Director of Social Medicine and Epidemiology at the University of Lübeck and scientific advisor to the German Mammography Screening Program. Hundreds of women are screened every week and we are very focused on launching further clinics and growing the ecosystem in Mexico, which was joined by large corporations as well as NGOs such as ProMujer. We’re also working on expanding our AI technology to other modalities, starting with 3D mammography (tomosynthesis) to be able to provide the best possible screening quality to women with dense breast tissue.